Nasopharyngeal Carcinoma (NPC) is a rare type of head and neck cancer that originates in the nasopharynx. Despite its rarity, NPC is associated with significant morbidity and mortality. Radiotherapy is the primary treatment modality for NPC; however, concerns regarding treatment failure rates and associated complications persist.
The management of peritoneal metastasis remain a controversial issue. The majority of medical society believes that this condition remains with pool prognosis and survival expectation remains to 3-6 months. On the other hand the selection of patients with strict criteria offers with locoregional treatments of Cytoreductive Surgery (CRS).
We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.